Automation

WHITE PAPERS AND CASE STUDIES

• How To Reduce The Complexity Of Custom Single-Use Assemblies

  What started out as a simple bag for holding buffers or cleaning solutions has evolved to thousands of single-use products and entire processes. The industry is now calling for standardization.

• How To Choose The Best Integrated Payments Provider

  As a POS developer, you are no doubt aware of the problems that come with choosing the right businesses to partner with. Can you trust them? Are they reliable and flexible? Do they offer excellent customer support? Will they be around in five years or will they be acquired by a company you want nothing to do with? You need answers to these questions before entering into that relationship. After all, your livelihood and the financial health of your company are on the line.

• Innovative Strategies To Maintain Product Integrity In Biologic & Biosimilar Clinical Studies

  Delays encountered during clinical studies can have a serious impact on competitive advantage, speed to market and the availability of lower-cost alternatives for patients. Specialized expertise in cold chain shipping and logistics are critical to avoid costly delays and potential for patient harm resulting from an interruption or delay in necessary clinical supply. Maintaining product integrity and reliability of supply can be especially challenging for biologic and biosimilar studies which will almost certainly require cold chain handling.

• The Evolution Of The Modern Medical Monitor

  How to identify, hire, and empower a modern medical monitor to help your next study proceed toward submission more productively, and with greater data integrity, than ever before.

• An Introduction To Particle Technology In Pharmaceutical Manufacturing

  A basic understanding of particles and particle counting to help improve your cleanliness levels. In this beginner's guide to particle technology, you will learn about the physical nature, origins and behavior of particles.

• Saving Development Time And Economizing Distribution With A Single-Vendor Approach

  By minimizing the overall time, complexity, and effort of clients’ projects and reducing the risks, Thermo Fisher’s most complete integrated offering represents a strong single-vendor solution.

• How Collaboration Transformed A Generic Into A Best-In-Class New Drug

  Learn how a drug developer collaborated to transform a generic solid active pharmaceutical ingredient (API) into a commercial, sterile injectable approved by regulators.

• How To Prepare For The Next Big Disruption

  Okay, yes, significant disruptions do happen. How did your organization respond to the COVID-19 pandemic? Hopefully, well — but because of the disruption in our normal business processes, we discovered weaknesses in our ability to service our customers. Aligning our business processes and technology is a good start toward fixing them. Here’s how to get it done.

• When Failure Is Not An Option

  The manufacture of Intelligence, Surveillance, & Reconnaissance (ISR) optics requires a rigorous analysis of the capabilities and methods of an optical component design/manufacturing partner. Not all design/manufacturing partners are the same, and it is important that integrators elect to work in a collaborative way with companies that have the expertise, pedigree and capabilities to scale up production of components in an accurate and repeatable way.

• Modular Bioprocessing Alleviates Drug Manufacturing Woes

  Building a bioprocessing facility is usually a complicated process and requires partnering with not only drug developers, but also many different experts in various industries.

• Automation: The Future Of Medical Device Manufacturing

  The expectation for zero defects in medical devices is higher than ever. Manufacturers must find ways to achieve that expectation while reducing costs and risks. This article explains how automation can help manufacturers reach those goals.

• 3 Strategies For Integrating Flexibility Into Clinical Supply Chain Planning

  Sometimes, clinical trials do not succeed because of incomplete planning and a lack of contingencies for when circumstances change. So, how do you plan for unanticipated obstacles that may affect the clinical supply chain and, ultimately, the outcome of your trial?